The Ridgewood Blog Brings a Free Market Laissez-faire Point of View to Local, New Jersey State and National Issues.
photo courtesy of Valley Hospital
the staff of the Ridgewood blog
Ridgewood NJ, Since the COVID-19 vaccine’s arrival at Valley nearly a month ago, thousands of our employees, doctors, and first responders have been vaccinated to ensure they can continue to care for you and others in the community.
the staff of the Ridgewood blog
Ridgewood NJ , according to the Johns Hopkins Center for Health Security ,since the onset of the pandemic, health experts and officials have studied the role of immunity conferred by natural infection. While reports of are relatively rare, the potential for reinfection does exist. In light of this risk, the US CDC emphasizes that individuals who were previously infected and recovered should still get vaccinated due to the “severe health risks” and uncertainty regarding the duration of natural immunity. Additionally, the degree of natural immunity “varies from person to person.” The duration of the immunity conferred by vaccination remains uncertain as well, but research is still ongoing via clinical trials. Depending on the duration of immunity following vaccination, it may be necessary for individuals to receive regular boosters to provide longer-term protection.
the staff of the Ridgewood blog
Teaneck NJ , In a Jan. 14th letter to New Jersey’s commissioners of health and education, the Orthodox Union’s Teach NJ called on the state to re-prioritize educators in its COVID-19 vaccination distribution. Teach NJ is a nonpartisan organization advocating on behalf of New Jersey nonpublic schools.
the staff of the Ridgewood blog
Englewood NJ, ShopRite announced on Monday that it will begin distributing the COVID-19 vaccine at 39 stores in New Jersey. Healthcare workers will be first in line and distribution will expand to others as more groups become eligible to be vaccinated.
Continue reading Select ShopRite Pharmacies to Distribute COVID-19 Vaccines to Healthcare Workers
the staff of the Ridgewood blog
New Brunswick NJ, earlier this week, New Jersey based Johnson & Johnson (J&J) reportedly announced that is reducing the size of its ongoing US SARS-CoV-2 vaccine clinical trial. The ongoing COVID-19 surge in the US actually benefits the trial by increasing the rate that participants are exposed and infected, meaning that the trial can meet its designated endpoint (e.g., specific number of cases) with fewer participants. In a recent press conference Dr. Moncef Slaoui, co-lead of Operation Warp Speed, emphasized that, while Pfizer and Moderna are moving closer to receiving Emergency Use Authorization, the J&J and AstraZeneca candidates are critical to the US government’s goal of vaccinating all Americans by summer 2021. J&J temporarily paused the Phase 3 clinical trials earlier this year in order to investigate an adverse event in the trial group, but it resumed the trial on October, 23.
Clinical Contributors to this Story Ihor Sawczuk, M.D. contributes to topics such as Medical Research, Urology.
Hackensack NJ, The United States has begun to roll out COVID-19 vaccines in an effort to help stop the pandemic. Millions of people will line up across the country to get the vaccine, expected to be approved by the U.S. government.
For many, we’ve never really thought about the approval process that every vaccine, including the COVID-19 vaccine, must go through before getting approved for public use. It’s an extensive and rigorous process to ensure it’s safe before it can be distributed to the community.
Continue reading Hackensack Meridian Health : Behind the COVID-19 Vaccine Approval Process
the staff of the Ridgewood compiled from the CDC website
Ridgewood NJ, In the United States, there is not yet an authorized or approved vaccine to prevent coronavirus disease 2019 (COVID-19). The federal government, through Operation Warp Speedexternal , has been working since the pandemic started to make one or more COVID-19 vaccines available as soon as possible. Although CDC does not have a role in developing COVID-19 vaccines, CDC has been working closely with health departments and partners to develop vaccination plans for when a vaccine is available.
With the possibility of one or more COVID-19 vaccines becoming available before the end of the year, here are things you need to know about where those plans currently stand.
